Orchestra BioMed
OBIO
OBIO
46 hedge funds and large institutions have $130M invested in Orchestra BioMed in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
15% less capital invested
Capital invested by funds: $154M → $130M (-$23.7M)
Holders
46
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.25M | |
| 2 | +$2.25M | |
| 3 | +$2.19M | |
| 4 |
AC
Athanor Capital
New York
|
+$669K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
+$280K |
Top Sellers
| 1 | -$2.56M | |
| 2 | -$2.37M | |
| 3 | -$1.68M | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$1.51M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$1.4M |